Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs von Gerstenfeld, Louis C, Thiede, Mark, Seibert, Karen, Mielke, Cindy, Phippard, Deborah, Svagr, Bohus, Cullinane, Dennis, Einhorn, Thomas A

Volltext

Pharmacological Analysis of Cyclooxygenase-1 in Inflammation von Smith, Christopher J., Zhang, Yan, Koboldt, Carol M., Muhammad, Jerry, Zweifel, Ben S., Shaffer, Alex, Talley, John J., Masferrer, Jaime L., Seibert, Karen, Isakson, Peter C.

Volltext

The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate von Wang, Jane L., Carter, Jeffery, Kiefer, James R., Kurumbail, Ravi G., Pawlitz, Jennifer L., Brown, David, Hartmann, Susan J., Graneto, Matthew J., Seibert, Karen, Talley, John J.

Volltext

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents von Kurumbail, Ravi G., Stevens, Anna M., Gierse, James K., McDonald, Joseph J., Stegeman, Roderick A., Pak, Jina Y., Gildehaus, Daniel, iyashiro, Julie M., Penning, Thomas D., Seibert, Karen, Isakson, Peter C., Stallings, William C.

Volltext

COX-2 Inhibitors: A New Class of Antiangiogenic Agents von MASFERRER, JAIME L., KOKI, ALANE, SEIBERT, KAREN

Volltext

Kinetic basis for selective inhibition of cyclo-oxygenases von Gierse, J K, Koboldt, C M, Walker, M C, Seibert, K, Isakson, P C

Volltext

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis von Fischer, Susan M., Lo, Herng-Hsang, Gordon, Gary B., Seibert, Karen, Kelloff, Gary, Lubet, Ronald A., Conti, Claudio J.

Volltext

Selective Inhibition of Inducible Cyclooxygenase 2 in vivo is Antiinflammatory and Nonulcerogenic von MASFERRER, J. L, ZWEIFEL, B. S, MANNING, P. T, HAUSER, S. D, LEAHY, K. M, SMITH, W. G, ISAKSON, P. C, SEIBERT, K

Volltext

A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors von Walker, M C, Kurumbail, R G, Kiefer, J R, Moreland, K T, Koboldt, C M, Isakson, P C, Seibert, K, Gierse, J K

Volltext

Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors von Carter, Jeffery S., Kramer, Steven, Talley, John J., Penning, Thomas, Collins, Paul, Graneto, Matthew J., Seibert, Karen, Koboldt, Carol M., Masferrer, Jaime, Zweifel, Ben

Volltext

Characterization of Celecoxib and Valdecoxib Binding to Cyclooxygenase von Hood, William F., Gierse, James K., Isakson, Peter C., Kiefer, James R., Kurumbail, Ravi G., Seibert, Karen, Monahan, Joseph B.

Volltext

Clinical next‐generation sequencing in patients with non–small cell lung cancer von Hagemann, Ian S., Devarakonda, Siddhartha, Lockwood, Christina M., Spencer, David H., Guebert, Kalin, Bredemeyer, Andrew J., Al‐Kateb, Hussam, Nguyen, TuDung T., Duncavage, Eric J., Cottrell, Catherine E., Kulkarni, Shashikant, Nagarajan, Rakesh, Seibert, Karen, Baggstrom, Maria, Waqar, Saiama N., Pfeifer, John D., Morgensztern, Daniel, Govindan, Ramaswamy

Volltext

314: ACCURACY OF OFF-LABEL USE OF BLOOD GLUCOSE METER IN THE CRITICAL CARE POPULATION von Stewart, Amy, Seibert, Karen, Villines, Dana, Saeedi, Joel, Chaiban, Joumana, Yasmeen, Tahira, Ries, Michael

Volltext

1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents von Khanna, Ish K, Weier, Richard M, Yu, Yi, Xu, Xiang D, Koszyk, Francis J, Collins, Paul W, Koboldt, Carol M, Veenhuizen, Amy W, Perkins, William E, Casler, Jacquelen J, Masferrer, Jaime L, Zhang, Yan Y, Gregory, Susan A, Seibert, Karen, Isakson, Peter C

Volltext

N-[[(5-Methyl-3-phenylisoxazol-4-yl)- phenyl]sulfonyl]propanamide, Sodium Salt, Parecoxib Sodium:  A Potent and Selective Inhibitor of COX-2 for Parenteral Administration von Talley, John J, Bertenshaw, Stephen R, Brown, David L, Carter, Jeffery S, Graneto, Matthew J, Kellogg, Michael S, Koboldt, Carol M, Yuan, Jinhua, Zhang, Yan Y, Seibert, Karen

Volltext

A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors von Gierse, J K, McDonald, J J, Hauser, S D, Rangwala, S H, Koboldt, C M, Seibert, K

Volltext

Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology von Cottrell, Catherine E, Al-Kateb, Hussam, Bredemeyer, Andrew J, Duncavage, Eric J, Spencer, David H, Abel, Haley J, Lockwood, Christina M, Hagemann, Ian S, O’Guin, Stephanie M, Burcea, Lauren C, Sawyer, Christopher S, Oschwald, Dayna M, Stratman, Jennifer L, Sher, Dorie A, Johnson, Mark R, Brown, Justin T, Cliften, Paul F, George, Bijoy, McIntosh, Leslie D, Shrivastava, Savita, Nguyen, TuDung T, Payton, Jacqueline E, Watson, Mark A, Crosby, Seth D, Head, Richard D, Mitra, Robi D, Nagarajan, Rakesh, Kulkarni, Shashikant, Seibert, Karen, Virgin, Herbert W, Milbrandt, Jeffrey, Pfeifer, John D

Volltext

The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis von JACOBY, Russell F, SEIBERT, Karen, COLE, Carolyn E, KELLOFF, Gary, LUBET, Ronald A

Volltext

Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain von Breder, Christopher D., Smith, William L., Raz, Amiram, Masferrer, Jamie, Seibert, Karen, Needleman, Phillip, Saper, Clifford B.

Volltext

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis von KAWAMORI, T, RAO, C. V, SEIBERT, K, REDDY, B. S

Volltext